Net income
−$10.3M
−29.4% vs same quarter last year
EPS, diluted
−$0.23
−9.5% vs same quarter last year
Operating cash flow
−$5.9M
+9.9% vs same quarter last year
Operating income
−$10.4M
−26.9% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $8K | −$32.1M |
| FY24 | $8K | −$29.9M |
| FY23 | $170K | −$28.3M |
| FY22 | $11.1M | −$5.2M |
| FY21 | - | - |
- Operating margin
- Net margin
Show the numbers
| Year | Operating margin | Net margin |
|---|---|---|
| FY25 | −415175% | −401812.5% |
| FY24 | −396200% | −373362.5% |
| FY23 | −14214.7% | −16645.3% |
| FY22 | −27.2% | −47% |
| FY21 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$26.4M |
| FY24 | −$21.6M |
| FY23 | −$21.3M |
| FY22 | −$3.6M |
| FY21 | - |
- Genelux
- Healthcare median
Show the numbers
| Year | Genelux | Healthcare median |
|---|---|---|
| FY25 | −401812.5% | −30.6% |
| FY24 | −373362.5% | −47% |
| FY23 | −16645.3% | −58% |
| FY22 | −47% | −80.4% |
| FY21 | - | −71.9% |